Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 4
1993 1
1994 2
1995 1
1996 2
1997 1
1999 4
2002 2
2003 3
2004 1
2005 3
2006 7
2007 6
2008 8
2009 10
2010 3
2011 4
2012 7
2013 9
2014 7
2015 4
2016 3
2017 6
2018 15
2019 5
2020 1
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 25667260

108 results
Results by year
Filters applied: . Clear all
Page 1
Intravenous immunoglobulin as clinical immune-modulating therapy.
Gilardin L, Bayry J, Kaveri SV. Gilardin L, et al. CMAJ. 2015 Mar 3;187(4):257-264. doi: 10.1503/cmaj.130375. Epub 2015 Feb 9. CMAJ. 2015. PMID: 25667260 Free PMC article. Review. No abstract available.
Immune supplementation and immune modulation with intravenous immunoglobulin.
Mazer BD, Al-Tamemi S, Yu JW, Hamid Q. Mazer BD, et al. J Allergy Clin Immunol. 2005 Oct;116(4):941-4. doi: 10.1016/j.jaci.2005.07.021. J Allergy Clin Immunol. 2005. PMID: 16210080 No abstract available.
Intravenous immunoglobulins for rituximab-resistant mucous membrane pemphigoid.
Witte M, Zillikens D, Shimanovich I. Witte M, et al. J Eur Acad Dermatol Venereol. 2018 Aug;32(8):e321-e324. doi: 10.1111/jdv.14873. Epub 2018 Mar 6. J Eur Acad Dermatol Venereol. 2018. PMID: 29443427 No abstract available.
ASHP therapeutic guidelines for intravenous immune globulin. ASHP Commission on Therapeutics.
[No authors listed] [No authors listed] Clin Pharm. 1992 Feb;11(2):117-36. Clin Pharm. 1992. PMID: 1312920 Review. No abstract available.
Resistance to intravenous immunoglobulin (IVIG) in Kawasaki disease: no influence of different IVIG lot utilisation.
Pagnini I, Marino A, Simonini G, Cimaz R. Pagnini I, et al. Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S170. Epub 2012 May 11. Clin Exp Rheumatol. 2012. PMID: 22410254 No abstract available.
Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
Zeidman LA, Fahey CD, Grinblatt DL, Harsanyi K. Zeidman LA, et al. Pediatr Neurol. 2006 Jan;34(1):60-2. doi: 10.1016/j.pediatrneurol.2005.06.012. Pediatr Neurol. 2006. PMID: 16376282
[Immunoglobulin in suspected Kawasaki disease].
García Soblechero E, Gómez Santos E, Domínguez Quintero ML, González Vila L. García Soblechero E, et al. An Pediatr (Barc). 2010 Sep;73(3):151-2. doi: 10.1016/j.anpedi.2010.05.015. Epub 2010 Jul 4. An Pediatr (Barc). 2010. PMID: 20605119 Free article. Spanish. No abstract available.
Intravenous immunoglobulin therapy for refractory ocular cicatricial pemphigoid: case report.
Galdos M, Etxebarría J. Galdos M, et al. Cornea. 2008 Sep;27(8):967-9. doi: 10.1097/ICO.0b013e318172fbc5. Cornea. 2008. PMID: 18724167
External validation of a scoring system to predict resistance to intravenous immunoglobulin.
Kobayashi T, Inoue Y, Tamura K, Morikawa A, Kobayashi T. Kobayashi T, et al. J Pediatr. 2007 Apr;150(4):e37; author reply e38. doi: 10.1016/j.jpeds.2006.12.036. J Pediatr. 2007. PMID: 17382098 No abstract available.
A case of anti-BP180 type mucous membrane pemphigoid treated with intravenous immunoglobulin.
Aoki N, Nakajima K, Shiga T, Koga H, Hashimoto T, Sano S. Aoki N, et al. J Dermatol. 2014 Jun;41(6):557-9. doi: 10.1111/1346-8138.12502. J Dermatol. 2014. PMID: 24909219 No abstract available.
108 results
Jump to page
Feedback